Search Results for "Mylan Atovaquone And Proguanil 250mg 100mg Tablet"

15:59 EDT 21st October 2014 | BioPortfolio

Matching Channels

Pancreatic Cancer

The pancreas secretes a number of important hormones into the digestive tract and the blood stream. Cancers are most commonly exocrine than endocrine (neuroendocrine) tumors. Functional tumors secre...

Selective monoamine oxidase type B MAOB inhibitors

The clinical benefit of monoamine oxidase type B (MAO-B) inhibitors is thought to arise from an ability of these medications to enhance the level of dopamine by decreasing the catabolism. Additional...

Matching News

Mylan unveils generic malaria tablets

Pharmaceutical company Mylan (NasdaqGS:MYL) revealed on Thursday the market launch of Atovaquone and Proguanil Hydrochloride Tablets, 62.5 mg/25 mg and 250 mg/100 mg. The company added Atovaquone and ...

Mylan Launches Generic Malarone Tablets

CANONSBURG (dpa-AFX) - Mylan Inc. (MYL) said it has launched Atovaquone and Proguanil Hydrochloride Tablets, 62.5 mg/25 mg and 250 mg/100 mg, the generic version of GlaxoSmithKline's Malarone Tabl...

Mylan Launches Generic Malarone® Tablets

PITTSBURGH, May 29, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has launched Atovaquone and Proguanil Hydrochloride Tablets, 62.5 mg/25 mg and 250 mg/100 mg, the generic vers...

Mylan launches generic version of GlaxoSmithKline's Malarone Tablets

Mylan Inc. today announced that it has launched Atovaquone and Proguanil Hydrochloride Tablets, 62.5 mg/25 mg and 250 mg/100 mg, the generic version of GlaxoSmithKline's Malarone® Tablets.

Mylan settles patent litigation with Pfizer on generic Celebrex capsules

US-based pharmaceutical firm Mylan has entered into a settlement and license agreement with Pfizer relating to its Abbreviated New Drug Application (ANDA) filed with the US Food and Drug Administratio...

Actavis to settle patent challenge for Nuvigil with Cephalon

Irish pharmaceutical firm Actavis has entered into an agreement with Cephalon to settle all outstanding patent litigation related to the company's generic version of Nuvigil (armodafinil tablets, 50mg...

Actavis settles Nuvigil patent litigation with Cephalon

Ireland-headquartered generics major Actavis says it has entered into an agreement with Cephalon to settle all outstanding patent litigation related to Actavis' generic version of Nuvigil (armodafinil...

Mylan Signs Deal With Gilead Sciences On Sovaldi And Ledipasvir/Sofosbuvir

CANONSBURG (dpa-AFX) - Mylan Inc. (MYL) announced that its subsidiary Mylan Laboratories Limited has entered into an agreement with Gilead Sciences Inc. (GILD) under which Mylan has been licensed ...

Matching PubMed Articles

Epilepsy triggered by mefloquine in an adult traveler to Uganda.

We report a case of a traveler who visited Uganda for 8 d, and took mefloquine one tablet/week for malaria prophylaxis. After the second dose, he suffered from two episodes of loss of consciousness wi...

Emergence of resistance to atovaquone-proguanil in malaria parasites: insights from computational modeling and clinical case reports.

The usefulness of atovaquone-proguanil (AP) as antimalarial treatment is compromised by the emergence of atovaquone resistance during therapy. However, the origin of the parasite mitochondrial DNA (mt...

Notes from the Field: Knowledge, Attitudes, and Practices Regarding Antimalarial Chemoprophylaxis in U.S. Peace Corps Volunteers - Africa, 2013.

Long-term travelers to areas where malaria is endemic are at risk for this potentially fatal disease; however, malaria can be prevented through the use of insecticide-treated bednets, mosquito repelle...

Artenimol + piperaquine. Very slow piperaquine elimination: cardiovascular risks and interactions.

For the treatment of uncomplicated Plasmodium falciparum malaria, drug combinations based on artemisinin derivatives (such as artemether + lumefantrine in France) are an alternative to atovaquone + pr...

Subjective adverse reactions to metronidazole in patients with amebiasis.

Subjective adverse reactions to metronidazole were analyzed in 111 patients with amebiasis. Metronidazole was administered to 36 patients at a daily dose of 2,250mg and 75 patients at daily doses lowe...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement